TATACHEM.BOTATACHEM.BOBSE
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | -3.75% | +0.98% | -1.85% | -3.05% | -1.11% |
| Gross Profit Growth | +2.49% | +35.15% | +3.64% | -34.61% | -37.30% |
| EBITDA Growth | -23.36% | -33.81% | +18.95% | -0.97% | -17.13% |
| Operating Income Growth | -6.83% | +202.14% | +0.92% | -81.48% | -95.72% |
| Net Income Growth | -133.54% | +0.00% | +68.00% | -60.31% | +0.00% |
| EPS Growth | -133.55% | +0.00% | +86.60% | -60.32% | +0.00% |
| EPS Diluted Growth | -133.55% | +0.00% | +86.60% | -60.32% | +0.00% |
| Weighted Average Shares Growth | +0.02% | -24.05% | +0.02% | -0.07% | -0.02% |
| Weighted Average Shares Diluted Growth | +0.02% | +0.36% | +0.02% | -0.07% | -0.02% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | -100.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | -100.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +0.00% | -13.44% | +0.00% | -3.83% | +0.00% |
| Inventory Growth | +0.00% | +1.35% | +0.00% | +11.79% | +0.00% |
| Asset Growth | +0.00% | +2.79% | +0.00% | +3.28% | +0.00% |
| Book Value per Share Growth | +3.73% | +27.84% | -2.67% | +0.80% | +0.00% |
| Debt Growth | +0.00% | +27.13% | +0.00% | +15.68% | +0.00% |
| R&D Expense Growth | +0.00% | -100.00% | +0.00% | +0.00% | +0.00% |
| SG&A Expenses Growth | +14.34% | -6.37% | +6.73% | +18.99% | +23.21% |